Latest Ceo Appointments News

Xamble has appointed Adrian Tan permanent CEO and elevated Georg Johann Chmiel to chair as it seeks to convert recent operating improvements into sustained growth. Ganesh Kumar Bangah is stepping down from the board to take a senior Malaysian government-linked role but will remain involved as an adviser and substantial shareholder.

LinQ Minerals finished its first full year as an ASX-listed explorer with $16.23 million in cash after spending heavily on Gilmore drilling and raising $15.4 million. The company reported encouraging gold and copper results, but its next phase will test whether exploration success can translate into a larger resource and a credible development pathway.

49 Metals has elevated CEO Phil Carter to Managing Director while shifting Executive Director Oliver Kreuzer into a non-executive and consulting role. The restructure comes with A$265,000 in base pay for Carter and 5 million options exercisable at 25¢ and 30¢.

CVC Limited posted a net profit after tax of $7.7 million for FY2026, underpinned by a $37.8 million profit from the Laverton sale and a $13.3 million impairment from the Liverpool project. The company paid a special dividend and restructured leadership amid ongoing capital management efforts.

Coppermoly Limited’s Managing Director and CEO Dickson Leah has resigned immediately, prompting a board-led strategic review focused on short-term shareholder value amid ongoing exploration and acquisitions.

IPH Limited reported a 16.9% jump in net profit to $80.4 million for FY26, driven by strong Canadian growth and operational discipline, alongside a new CEO appointment and its inaugural sustainability report.

Yugo Metals is pushing ahead with exploration in Bosnia and Herzegovina, backed by a fresh $5 million capital raise and encouraging early gold results at its Sinjakovo Project. Preparations are underway for new drilling at Cajnice, while the company continues to expand its footprint in battery and base metals.

PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.

Arovella Therapeutics secured ethics approval and manufactured its first clinical batch of ALA-101, targeting blood cancers, while progressing its solid tumour program and refining autoimmune strategies. The company ended the quarter with $14.4 million in cash, supporting imminent clinical milestones.

Imugene's azer-cel therapy shows a third patient response in the BTKi combination cohort of its Phase 1b trial, while CEO Leslie Chong steps down after nearly 11 years, prompting a leadership search.

LinQ Minerals has delivered significant drilling results at its Gilmore Project, confirming a large shallow copper-gold porphyry system at Monza and extending high-grade gold-copper mineralisation at Dam. With a strong cash position and multiple assay results pending, the company is well placed for further exploration.

Latrobe Magnesium (ASX: LMG) is set for leadership change with Robert Stein stepping in as CEO from October 2026, while Peter Mizera takes charge of the Construction Committee, underpinning the company’s push towards magnesium metal production.